We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2025 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Tests Screens for Retinal Diseases

By LabMedica International staff writers
Posted on 01 Feb 2011
A custom resequencing chip has been designed to identify known and new mutations in retinal disease genes.

The retinal resequencing chip covers all exons of 90 retinal disease genes and it has been tested with multiplex primer sets for 1,445 amplicons representing the genes included on the chip.

A collaborative study carried out at the Netherlands Institute for Neuroscience (Amsterdam, The Netherlands), tested their retinal DNA resequencing chip and patient pooling strategy. This enabled detection of multiple retinal disease gene sequences in numerous patients, at the same time. DNA was extracted from peripheral blood from 60 patients with a variety of retinal disorders, including Leber's congenital amaurosis, ocular albinism, pseudoxanthoma elasticum, retinitis pigmentosa, and Stargardt's disease.

The custom 300-kb resequencing chip is designed for polymerase chain reaction (PCR) amplification, DNA fragmentation, and chip hybridization performance. Hybridization signals were analyzed using appropriate detection software and this resequencing approach was validated by Sanger sequence technology. The new chip can screen up to 90 retinal disease genes in as many as 20 patients at the same time and return results faster than current tests. Since 150 genes related to 30 retinal diseases have been identified, and on average, at least five genes must be considered for each type of disease.

Arthur A.B. Bergen, PhD, the lead author of the study, said, "In initial and replicated tests, we achieved a high 99% detection rates, 100% reproducibility of results and no false-positives. Unlike current methods, our chip can detect both known and new genetic sequence changes associated with retinal disorders, an advance that will further our understanding of disease mechanisms as well as improving diagnosis and treatment. The chip is fully validated for DNA diagnostic purposes, and an upgraded version will be available in early 2011 at the Netherlands Institute for Neuroscience, Amsterdam. The study was published in January 2011, in the journal Ophthalmology.

Related Links:
Netherlands Institute for Neuroscience



Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Staining System
RAL DIFF-QUIK
New
Automatic Hematology Analyzer
LABAS F9000

Latest Molecular Diagnostics News

DNA Methylation Signatures of Aging Could Help Assess Mortality Risk
01 Feb 2011  |   Molecular Diagnostics

Molecular Diagnostics System Provides Lab-Quality Results at POC
01 Feb 2011  |   Molecular Diagnostics

Cellular Signature Identifies Patients with Treatment Resistant Prostate Tumors
01 Feb 2011  |   Molecular Diagnostics



PURITAN MEDICAL